TFA Therapeutics (RAJAF) Assets Average (2021 - 2025)

TFA Therapeutics has reported Assets Average for 5 years, with the latest figure at $4.6 million in Q4 2025.

• On a quarterly basis, Assets Average rose 16.37% year-over-year to $4.6 million in Q4 2025; TTM through Dec 2025 was $4.6 million, a 16.37% increase from a year earlier, with the FY2025 full-year figure at $4.6 million, up 16.37% from the prior year.
• Assets Average was $4.6 million for Q4 2025 at TFA Therapeutics, up from $4.0 million in the prior quarter.
• The five-year high for Assets Average was $4.6 million in Q4 2025, with the low at $2.0 million in Q3 2023.
• Average Assets Average over 5 years is $3.1 million, with a median of $2.9 million recorded in 2021.
• The sharpest annual moves came in 2022 and 2024: Assets Average retreated 11.84% in 2022, then soared 54.88% in 2024.
• Over 5 years, Assets Average stood at $3.0 million in 2021, then slipped by 11.84% to $2.7 million in 2022, then declined by 4.07% to $2.6 million in 2023, then jumped by 54.88% to $4.0 million in 2024, then climbed by 16.37% to $4.6 million in 2025.
• The last three Assets Average figures came in at $4.6 million (Q4 2025), $4.0 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.